Cart
sales@molnova.com
Home - Products - Others - Other Targets - Darutoside

Darutoside

CAS No. 59219-65-7

Darutoside( —— )

Catalog No. M18860 CAS No. 59219-65-7

Darutoside can as an appropriate treatment for wounds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 55 In Stock
2MG 29 In Stock
5MG 42 In Stock
10MG 69 In Stock
25MG 112 In Stock
50MG 164 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Darutoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Darutoside can as an appropriate treatment for wounds.
  • Description
    Darutoside can as an appropriate treatment for wounds. Darutoside can improve skin elasticity, surface appearance and stretch mark removal, through soothing the skin, decreasing inflammation, restoring collagen and promoting collagen production.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    59219-65-7
  • Formula Weight
    484.63
  • Molecular Formula
    C26H44O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (206.35 mM)
  • SMILES
    CC1(C2CCC3=CC(CCC3C2(CCC1OC4C(C(C(C(O4)CO)O)O)O)C)(C)C(CO)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Substance P 1-7

    Substance P 1-7 is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP)with anti-inflammatory anti-nociceptive and anti-hyperalgesic effects.

  • Butesuperin B-7-O-be...

    Butesuperin B-7''-O-beta-glucopyranoside

  • Rhamnazin

    Rhamnazin is an orally active inhibitor of VEGFR2 signaling with an IC50 of 4.68 μM against VEGFR2 kinase. Rhamnazin shows potent antiangiogenic activity and antitumor efficacy. Rhamnazin shows antioxidant and anti-inflammatory properties.

Sign In Join Free